Majedie Investments appoints Christopher Getley and Richard Killingbeck to its Board as Non-Executive Directors

– UK, London –  Majedie Investments PLC (LON: MAJE) today announced the appointments of Christopher Getley and Richard Killingbeck to its Board as Non-Executive Directors effective from 1 July 2020. They have also been appointed as members of the Audit, Remuneration, Management Engagement and Nomination Committees.

The Board also announces the retirement of Paul Gadd, who has served on the Board since 2009, with effect from 31 July 2020. The Board would like to thank him for his wise counsel as a member of the Board and also as Chairman of the Remuneration and Management Engagement Committees.

About Christopher Getley

Mr Getley has extensive knowledge of the investment industry as a Partner and Fund Manager at Cazenove and as a Director of Morgan Grenfell Asset Management. Subsequently, he was CEO of Westhouse Securities, an institutional stockbroker. He is currently Executive Chairman of AgPlus Diagnostics Limited and Non-Executive Chairman of Masawara PLC, a Southern Africa focussed investment company.

About Richard Killingbeck

Mr Killingbeck has over 35 years’ experience in the financial services sector, initially as a fund manager and latterly in a number of senior management roles within the wealth management sector. He was previously Chief Executive Officer of WH Ireland Group PLC and is currently Managing Director of Harris Allday, a subsidiary of EFG Private Bank. He retired as the Non-Executive Chairman of Bankers Investment Trust PLC in 2019 and is currently a trustee of the London Stock Exchange Benevolent Fund.

For more information :

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.